Latest Strategy News

GQG Partners reported robust financial results for 2024 with significant growth in funds under management and earnings, underscoring its adaptability and alignment with shareholders. The 2025 Annual Meeting confirmed strong investor confidence with near-unanimous director re-election.

Solstice Minerals has pinpointed promising mineral resource extension targets at its Nanadie Copper-Gold Project in Western Australia, setting the stage for a potential significant increase in copper and gold resources.

Altamin Limited has reported the final tranche of high-grade zinc-lead-silver assay results from its 2024 channel sampling at the Gorno Project, revealing mineralisation beyond current resource boundaries. These findings highlight new zones in previously inaccessible areas, reinforcing the project's exploration potential.

Arika Resources has identified 10 significant new gold targets at its Ithaca Prospect near Genesis Minerals’ Ulysses-Orient Well operation, setting the stage for upcoming drill testing at the Kookynie Gold Project.

New Frontier Minerals advances its NWQ Copper Project by securing bulk sample processing at Austral Resources’ Mt Kelly plant, accelerating its path to copper production in Queensland’s Mt Isa Copper Belt.

Australian Agricultural Company Limited (AACo) reported a 14% rise in operating profit to $58.4 million for FY25, driven by increased sales volumes and disciplined cost control despite challenging market conditions. The company also marked a significant reduction in statutory loss, signaling improved financial resilience.

Australian Agricultural Company Limited (AACo) reported a robust FY25 operating profit of $58.4 million, driven by increased meat and cattle sales volumes and strategic brand growth despite inflationary pressures.

Oceania Healthcare reported a 4.1% rise in underlying EBITDA for FY25, driven by strong sales and operational improvements, while launching a new strategic plan focused on growth and efficiency.

AFT Pharmaceuticals reported a 6% revenue increase to NZ$208 million in FY25, driven by strong ANZ growth and expanding international presence. The company targets NZ$300 million revenue by FY27 amid ongoing R&D and new product launches.

AFT Pharmaceuticals has reported record revenue of NZD 208 million for FY25, driven by strong Australasian sales and a recovery in Asia and international markets. The company is targeting NZD 300 million in revenue by FY27, supported by an expanded R&D pipeline and ongoing geographic diversification.

Smart Parking Limited reports robust H1 FY25 growth driven by a strategic US acquisition and expanding global footprint, underpinned by proprietary AI technology.

WestStar Industrial’s subsidiary SIMPEC has landed a $17 million contract to deliver key construction works for a pioneering lithium refining plant in Western Australia, marking a significant step in Australia’s energy transition.